Chun Ho-Yan Yvonne, Whiteley William N, Dennis Martin S, Mead Gillian E, Carson Alan J
From the Stroke Research Group, Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom.
Stroke. 2018 Mar;49(3):556-564. doi: 10.1161/STROKEAHA.117.020078. Epub 2018 Feb 6.
Anxiety after stroke is common and disabling. Stroke trialists have treated anxiety as a homogenous condition, and intervention studies have followed suit, neglecting the different treatment approaches for phobic and generalized anxiety. Using diagnostic psychiatric interviews, we aimed to report the frequency of phobic and generalized anxiety, phobic avoidance, predictors of anxiety, and patient outcomes at 3 months poststroke/transient ischemic attack.
We followed prospectively a cohort of new diagnosis of stroke/transient ischemic attack at 3 months with a telephone semistructured psychiatric interview, Fear Questionnaire, modified Rankin Scale, EuroQol-5D5L, and Work and Social Adjustment Scale.
Anxiety disorder was common (any anxiety disorder, 38 of 175 [22%]). Phobic disorder was the predominant anxiety subtype: phobic disorder only, 18 of 175 (10%); phobic and generalized anxiety disorder, 13 of 175 (7%); and generalized anxiety disorder only, 7 of 175 (4%). Participants with anxiety disorder reported higher level of phobic avoidance across all situations on the Fear Questionnaire. Younger age (per decade increase in odds ratio, 0.64; 95% confidence interval, 0.45-0.91) and having previous anxiety/depression (odds ratio, 4.38; 95% confidence interval, 1.94-9.89) were predictors for anxiety poststroke/transient ischemic attack. Participants with anxiety disorder were more dependent (modified Rankin Scale score 3-5, [anxiety] 55% versus [no anxiety] 29%; <0.0005), had poorer quality of life on EQ-5D5L, and restricted participation (Work and Social Adjustment Scale: median, interquartile range, [anxiety] 19.5, 10-27 versus [no anxiety] 0, 0-5; <0.001).
Anxiety after stroke/transient ischemic attack is predominantly phobic and is associated with poorer patient outcomes. Trials of anxiety intervention in stroke should consider the different treatment approaches needed for phobic and generalized anxiety.
卒中后焦虑很常见且会导致功能障碍。卒中试验者将焦虑视为一种同质疾病,干预研究也照此进行,忽视了针对恐惧症性焦虑和广泛性焦虑的不同治疗方法。通过诊断性精神科访谈,我们旨在报告恐惧症性焦虑和广泛性焦虑的发生率、恐惧回避情况、焦虑的预测因素以及卒中/短暂性脑缺血发作后3个月时的患者结局。
我们对一组新诊断为卒中/短暂性脑缺血发作的患者进行前瞻性随访,随访3个月,采用电话半结构式精神科访谈、恐惧问卷、改良Rankin量表、欧洲五维健康量表(EuroQol-5D5L)和工作与社会适应量表。
焦虑症很常见(任何焦虑症,175例中有38例[22%])。恐惧症性障碍是主要的焦虑亚型:仅恐惧症性障碍,175例中有18例(10%);恐惧症性和广泛性焦虑症,175例中有13例(7%);仅广泛性焦虑症,175例中有7例(4%)。患有焦虑症的参与者在恐惧问卷中报告在所有情况下恐惧回避水平更高。年龄较小(每增加十岁,比值比为0.64;95%置信区间,0.45 - 0.91)以及既往有焦虑/抑郁史(比值比,4.38;95%置信区间,1.94 - 9.89)是卒中/短暂性脑缺血发作后焦虑的预测因素。患有焦虑症的参与者更依赖他人(改良Rankin量表评分3 - 5分,[有焦虑]55% 对 [无焦虑]29%;<0.0005),在欧洲五维健康量表上生活质量较差,并且参与受限(工作与社会适应量表:中位数,四分位间距,[有焦虑]19.5,10 - 27 对 [无焦虑]0,0 - 5;<0.001)。
卒中/短暂性脑缺血发作后的焦虑主要是恐惧症性的,并且与较差的患者结局相关。卒中焦虑干预试验应考虑针对恐惧症性焦虑和广泛性焦虑所需的不同治疗方法。